First Eagle Investment Management LLC Has $275.22 Million Stock Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

First Eagle Investment Management LLC grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 2.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,500,409 shares of the medical instruments supplier's stock after acquiring an additional 348,532 shares during the period. First Eagle Investment Management LLC owned 7.29% of DENTSPLY SIRONA worth $275,218,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of XRAY. Cooke & Bieler LP raised its position in DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock worth $174,101,000 after purchasing an additional 1,794,391 shares during the last quarter. FMR LLC raised its position in DENTSPLY SIRONA by 5.1% in the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier's stock worth $245,076,000 after purchasing an additional 436,031 shares during the last quarter. Pacer Advisors Inc. raised its position in DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Bank of New York Mellon Corp raised its position in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock worth $45,611,000 after purchasing an additional 523,692 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in DENTSPLY SIRONA by 1.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock worth $39,880,000 after purchasing an additional 35,360 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

Remove Ads

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Stock Up 1.0 %

NASDAQ XRAY traded up $0.15 on Tuesday, reaching $15.74. The company had a trading volume of 2,288,980 shares, compared to its average volume of 2,972,147. The firm has a market capitalization of $3.13 billion, a price-to-earnings ratio of -7.60, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA Inc. has a 1-year low of $14.78 and a 1-year high of $33.72. The company's fifty day moving average is $18.22 and its 200-day moving average is $20.81.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.07%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's payout ratio is presently -14.07%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on XRAY shares. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Morgan Stanley dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research report on Tuesday, December 17th. Evercore ISI reiterated an "in-line" rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Finally, Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their target price for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Twelve equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA has an average rating of "Hold" and a consensus price target of $23.33.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.